Company Quick10K Filing
Royal Gold
10-Q 2021-03-31 Filed 2021-05-06
10-Q 2020-12-31 Filed 2021-02-04
10-Q 2020-09-30 Filed 2020-11-05
10-K 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-07
10-Q 2019-12-31 Filed 2020-02-06
10-Q 2019-09-30 Filed 2019-11-07
10-K 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-02
10-Q 2018-12-31 Filed 2019-02-07
10-Q 2018-09-30 Filed 2018-11-01
10-K 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-03
10-Q 2017-12-31 Filed 2018-02-08
10-Q 2017-09-30 Filed 2017-11-02
10-K 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-10
10-Q 2016-12-31 Filed 2017-02-02
10-Q 2016-09-30 Filed 2016-11-03
10-K 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-04-28
10-Q 2015-12-31 Filed 2016-02-04
10-Q 2015-09-30 Filed 2015-11-05
10-K 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-04-30
10-Q 2014-12-31 Filed 2015-01-29
10-Q 2014-09-30 Filed 2014-10-30
10-K 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-01
10-Q 2013-12-31 Filed 2014-01-30
10-Q 2013-09-30 Filed 2013-11-07
10-K 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-02
10-K 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-03
10-Q 2011-09-30 Filed 2011-11-03
10-K 2011-06-30 Filed 2011-08-18
10-Q 2011-03-31 Filed 2011-05-06
10-Q 2010-12-31 Filed 2011-02-04
10-Q 2010-09-30 Filed 2010-11-05
10-K 2010-06-30 Filed 2010-08-26
10-Q 2010-03-31 Filed 2010-05-07
10-Q 2009-12-31 Filed 2010-02-05
8-K 2020-11-18
8-K 2020-11-04
8-K 2020-10-13
8-K 2020-09-30
8-K 2020-09-30
8-K 2020-09-16
8-K 2020-08-05
8-K 2020-07-07
8-K 2020-05-06
8-K 2020-04-09
8-K 2020-02-05
8-K 2019-12-05
8-K 2019-11-20
8-K 2019-11-06
8-K 2019-10-30
8-K 2019-10-11
8-K 2019-09-26
8-K 2019-08-07
8-K 2019-06-11
8-K 2019-06-03
8-K 2019-05-30
8-K 2019-05-01
8-K 2019-02-25
8-K 2019-02-14
8-K 2019-02-06
8-K 2019-01-01
8-K 2018-11-14
8-K 2018-10-31
8-K 2018-09-19
8-K 2018-08-08
8-K 2018-06-18
8-K 2018-05-30
8-K 2018-05-02
8-K 2018-02-07

Royal Gold Financials

RGLD Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3227112611412396183375302681673664638659646660691675715743104118123117133848886889810989117157216119122
Accounts Receivable
Inventory
PP&E
Assets1,8631,8641,9131,9031,8921,9942,1092,3732,4032,8872,8942,9052,9022,8892,8832,8922,8932,8632,9102,9253,2293,2233,0993,0673,1493,1603,1293,0913,0663,0292,7532,6822,6732,6752,6992,5442,548
Accounts Payable2332232332232234232583346224323952533
Long-Term Debt216200229210192288114293295298300302305307309312314317319322675677630645715715670620570520445370370370370220170
Liabilities421409443415389479303510517514516535528520522519515505497510869861818781850850812770736730623541534528539374326
Stockholders' Equity1,4121,4271,4431,4601,4781,4901,7811,8381,8612,3482,3542,3492,3542,3482,3432,3552,3612,3412,3502,3532,2972,3012,2222,2292,2452,2602,2682,2752,2872,2582,0892,1022,1032,1122,1252,1372,190
Income Statement ($MM)2010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue6310098110116119
Cost of Revenue17181919160
Gross Profit76769584858992949594837991-7559
R&D
SG&A443106545667575467126710688118510710811107767
Tax7111010121415131618181356444-216595-857568848-4654-296-24
Net Income132120232624272125287141519201719-62515-4514-69182727222029-15-154271524292670
Cash Flow ($MM)2010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating3427414546294739541168403535453252306644252664955707672761057745777271
Cash Investing-24-2532-304-148-45-83-120-95-62-33-48-0-31-5-6-33-11-1-976-246-15-90-101-110-0-2-8-0-1-10
Cash Financing-13-2412-26-419185236-7463-14-17-14-13-27-13-14-13-15-15335-15-66-4152-18-61-69-66-91-89-16-17-168-69